Table 3 Adverse events
Adverse events n(%) | n(%) |
|---|---|
upper respiratory tract infection | 7(6.9%) |
bacterial pneumonia | 2(2.0%) |
fungal pneumonia | 1(1.0%) |
gastrointestinal infection | 2(2.0%) |
urinary tract infection | 1(1.0%) |
herpes zoster | 1(1.0%) |
allergic reaction to the infusion | 1(1.0%) |